Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis
NCT01977118Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pancreatitis (AP) comparing Streptokinase with Placebo (2 arms). Primary endpoints: Sepsis reversal at 1 month and Mortality at 1 month. Started May 2013; status: completed.
02
Drugs
streptokinase
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT01977118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977118.